» Articles » PMID: 7480550

The Delta Opioid Receptor Antagonist Naltrindole Attenuates Both Alcohol and Saccharin Intake in Rats Selectively Bred for Alcohol Preference

Overview
Specialty Pharmacology
Date 1995 Jul 1
PMID 7480550
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

This study demonstrates that the selective delta receptor antagonists ICI 174864 and naltrindole (NTI) attenuate alcohol intake in a dose-dependent manner, without altering water intake, in rats selectively bred for alcohol preference. ICI 174864 had a very limited duration of action, as evidenced by the fact that suppression of alcohol intake lasted for only an hour following ICI 174864 administration. NTI, when administered in a dose of 10 mg/kg, suppressed alcohol intake by 28%. Increasing the dose of NTI to 15 mg/kg produced a 44% suppression of alcohol intake, but a further increase to 20 mg/kg did not produce greater suppression than was seen with a dose of 15 mg/kg (46% versus 44%, respectively). This suggests that NTI is maximally effective in suppressing alcohol intake at a dose of 15.0 mg/kg. NTI displayed a long duration of action, as evidenced by attenuation of alcohol drinking that lasted for at least 8 h following drug treatment. Administering the maximally effective dose of NTI (15 mg/kg) in two parts, separated by 4 h, served to prolong the duration of action of NTI and produced an attenuation of alcohol intake, but not water intake, that lasted for at least 28 h. The effect of NTI on alcohol intake was not specific for alcohol, as evidenced by the fact that NTI reduced the intake of saccharin solutions with and without alcohol.

Citing Articles

Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder.

Gutridge A, Chakraborty S, Varga B, Rhoda E, French A, Blaine A Front Pharmacol. 2021; 12:764885.

PMID: 34803709 PMC: 8596301. DOI: 10.3389/fphar.2021.764885.


Behavioral, neurobiological, and neurochemical mechanisms of ethanol self-administration: A translational review.

Vena A, Zandy S, Cofresi R, Gonzales R Pharmacol Ther. 2020; 212:107573.

PMID: 32437827 PMC: 7580704. DOI: 10.1016/j.pharmthera.2020.107573.


Delta Opioid Pharmacology in Relation to Alcohol Behaviors.

Alongkronrusmee D, Chiang T, van Rijn R Handb Exp Pharmacol. 2016; 247:199-225.

PMID: 27316912 PMC: 5164984. DOI: 10.1007/164_2016_30.


A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Bell R, Hauser S, Rodd Z, Liang T, Sari Y, McClintick J Int Rev Neurobiol. 2016; 126:179-261.

PMID: 27055615 PMC: 4851471. DOI: 10.1016/bs.irn.2016.02.017.


The opioid receptors as targets for drug abuse medication.

Noble F, Lenoir M, Marie N Br J Pharmacol. 2015; 172(16):3964-79.

PMID: 25988826 PMC: 4543606. DOI: 10.1111/bph.13190.


References
1.
DE WAELE J, Papachristou D, Gianoulakis C . The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic beta-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice. J Pharmacol Exp Ther. 1992; 261(2):788-94. View

2.
Self D, Stein L . Receptor subtypes in opioid and stimulant reward. Pharmacol Toxicol. 1992; 70(2):87-94. DOI: 10.1111/j.1600-0773.1992.tb00435.x. View

3.
Brown D, Holtzman S . Opiate antagonists: central sites of action in suppressing water intake of the rat. Brain Res. 1981; 221(2):432-6. DOI: 10.1016/0006-8993(81)90796-4. View

4.
Magnen J, MARFAING-JALLAT P, Miceli D, Devos M . Pain modulating and reward systems: a single brain mechanism?. Pharmacol Biochem Behav. 1980; 12(5):729-33. DOI: 10.1016/0091-3057(80)90157-4. View

5.
Overstreet D, Kampov-Polevoy A, Rezvani A, Murrelle L, Halikas J, Janowsky D . Saccharin intake predicts ethanol intake in genetically heterogeneous rats as well as different rat strains. Alcohol Clin Exp Res. 1993; 17(2):366-9. DOI: 10.1111/j.1530-0277.1993.tb00777.x. View